Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vital KSK Holdings's other long-term liabilities for the quarter that ended in Mar. 2026 was 円13,142 Mil.
Vital KSK Holdings's quarterly other long-term liabilities
increased
from Sep. 2025 (円10,585 Mil) to Dec. 2025 (円11,374 Mil) and
increased
from Dec. 2025 (円11,374 Mil) to Mar. 2026 (円13,142 Mil).
Vital KSK Holdings's annual other long-term liabilities
declined
from Mar. 2024 (円10,233 Mil) to Mar. 2025 (円10,097 Mil) but then
increased
from Mar. 2025 (円10,097 Mil) to Mar. 2026 (円13,142 Mil).
Vital KSK Holdings Other Long-Term Liabilities Related Terms
Vital KSK Holdings Other Long-Term Liabilities Historical Data
* Premium members only.
The historical data trend for Vital KSK Holdings's Other Long-Term Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vital KSK Holdings Other Long-Term Liabilities Chart
Vital KSK Holdings Other Long-Term Liabilities Calculation
Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.
What does a Other Long-Term Liabilities of 円13,142 Mil mean?
Vital KSK Holdings (TSE:3151) has a Other Long-Term Liabilities of 円13,142 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Vital KSK Holdings and its competitors.
Is Vital KSK Holdings' Other Long-Term Liabilities too high?
Vital KSK Holdings' current Other Long-Term Liabilities is 円13,142 Mil. Overall, Vital KSK Holdings has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' Other Long-Term Liabilities compare to MCK and COR?
Vital KSK Holdings' Other Long-Term Liabilities of 円13,142 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Distribution company?
A good Other Long-Term Liabilities depends on the Medical Distribution industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Vital KSK Holdings and its competitors. Vital KSK Holdings's current Other Long-Term Liabilities is 円13,142 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,334.10, compared to a current price of 円1,586.00 — trading 18.9% above its estimated fair value. The current Other Long-Term Liabilities is 円13,142 Mil. Vital KSK Holdings' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current Other Long-Term Liabilities is 円13,142 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of 円1,586.00 is trading 18.9% above its estimated GF Value™ of 円1,334.10.
GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.
Key valuation signals for TSE:3151:
Other Long-Term Liabilities: 円13,142 Mil
GF Value™: 円1,334.10 vs. price of 円1,586.00 (18.9% above fair value)
No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
63GF Score
Get the complete analysis for TSE:3151
Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3151 has been successfully added to your 
